Overdose from opiates has skyrocketed. According to the National Center for Health Statistics, on average, 130 Americans die every day from an opioid overdose. The high cost of antidotes such as NARCAN® prevents many first responders from having access to lifesaving antidotes when they need it most.
Researchers at the Donald Danforth Plant Science Center have identified a new method of producing these compounds using a microorganism discovered in a waste stream associated with the processing of opium poppy. This green chemistry process has the potential to greatly reduce the cost of the antidote drugs as well as decrease chemicals currently used that result in large amounts of harmful waste. Details of the discovery were published as the cover story in the journal Nature Sustainability: “Enzyme morphinan N-demethylase for more sustainable opiate processing”.
“Enzymes perform reactions at efficiencies that surpass synthetic chemistry, thereby reducing the cost and impact of drug production on the environment. We work now to optimize production levels of the enzyme to a scale sufficient for industrial processes. Greener manufacturing would make a difference in people’s lives,” said Megan Augustin, lead author and research associate in the Kutchan lab at the Danforth Center.
Naturally occurring opiates, such as morphine and thebaine, are produced in poppy species. Thebaine is converted into painkillers and opiate addiction treatments, the latter requiring a chemical reaction called N-demethylation. Current opiate N-demethylation utilizes noxious reagents, resulting in harmful waste. One way to make opiate production more sustainable is to use enzymes rather than chemicals. Microorganisms provide a rich source of enzymes useful for metabolizing unique compounds in their environment. Augustin and her colleagues probed an opium processing waste stream sample to identify an organism capable of catalyzing opiate N-demethylation. To identify a biocatalyst, a sludge sample was subjected to minimal medium containing thebaine as the sole carbon source. This led to the discovery of Thebainfresser, a Methylobacterium that metabolizes opiates by removing the N-methyl group. N-demethylation was induced following growth in minimal medium, a characteristic that led to discovery of the underlying gene MND(morphinan N-demethylase). The enzyme MND was found to be robust and versatile, N-demethylating structurally diverse substrates at varying temperatures and pH levels. In addition, MND tolerated selected organic solvents and maintained activity when immobilized. These properties make it an attractive candidate for further development for pharmaceutical manufacture.
The Latest on: Opioid antidotes
via Google News
The Latest on: Opioid antidotes
- Watch now: Danville Fire Department now carrying Narcan, providing a dose of extra time for overdoseson January 18, 2022 at 10:00 am
Calling the tool a "game-changer," the Danville Fire Department is now carrying Narcan in its vehicles to provide for victims of opioid overdoses.
- Connecticut school where student overdosed closed for cleaningon January 18, 2022 at 9:25 am
The school in Hartford where a 13-year-old boy died from an fentanyl overdose was closed Tuesday in order to decontaminate it.
- Connecticut 13-year-old in 'guarded' condition after fentanyl overdose at schoolon January 17, 2022 at 7:01 pm
Connecticut authorities found an unconscious 13-year-old boy at his prep school Thursday morning, suffering an apparent opioid overdose on campus. Police arrived at Hartford’s Sport and Medical ...
- State: Naloxone distribution at community sites declined during pandemic’s first yearon January 16, 2022 at 6:57 am
Distribution of naloxone, the opioid-overdose antidote, declined at community sites in Vermont during the first year of the pandemic, a recent state report shows. Until then, naloxone distribution had ...
- Sackler-Owned Opioid Maker Pushes Drug for Overdoseson January 14, 2022 at 4:00 pm
Mundipharma is now marketing Nyxoid, a new brand of naloxone, an opioid overdose reversal medication. (AP Photo/Leila Coker) (AP) — The gleaming white booth towered over the medical conference in ...
- An Anti-overdose Drug Is Getting Stronger. Maybe That’s a Bad Thing?on January 14, 2022 at 8:12 am
but the impulse to strengthen naloxone reduces the problem to a battle between more potent forms of opioids and more potent forms of the antidotes that neutralize them. If only the way out of this ...
- Researchers Developing Vaccine to Fight Opioid Use Disorderon January 14, 2022 at 8:04 am
A new vaccine being developed could be used to help those prone to Opioid Use Disorder and opiate addiction. Scientists with a new research center at the University of Washington are working on a ...
- Prevention Centers Save Lives, But Only Radical Change Will End the Overdose Crisison January 12, 2022 at 3:21 pm
Confronting the overdose crisis will require a society-wide transformation in how we approach the issue of drug use.
- An Opioid Vaccine Is Not the Answeron January 10, 2022 at 10:58 am
Human trials are underway for a vaccine against the effects of prescription opioids. The researchers plan to later pursue a fentanyl vaccine.
- New law: Opioids may come with antidoteson January 6, 2022 at 6:30 am
Gov. Hochul signed into law on Dec. 30 legislation that will require medical professionals prescribing opioids to co-prescribe antidotes when specific risk factors are present. The bill was co-sponsor ...
via Bing News